N/A N=324 Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children
Malnutrition · Developmental Disabilities
Primary: Change in Height/Length for Age Z Score — -0.02; 0.05 Z scores
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=46 Growth Retardation In Children With Special Pathological Conditions Or Disease
Endocrine System Diseases
Primary: Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36 in Intent-to-Treat (ITT) Population — -1.29; 2.36 SDS
Phase 3 N=199 Weekly Zinc Chelate Supplementation on Children's Growth
Short Stature
Primary: Change in Height-for-Age Z-score (HAZ) From End of Supplementation to End of Follow-up Period. — 0.04; -0.08; 0.10; 0.02 Z-Score — p=<0.05
Phase 3 N=91 Saizen in Intra-uterine Growth Retardation
Children Born With Serious Intra-uterine Growth Retardation
Primary: Final Height — 145.90; 150.06; 153.27; 155.59 cm
Phase 3 N=208 Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
Growth Disorders · Intrauterine Growth Retardation
Primary: Change From Baseline in Annual Growth Rate Measured at 2 Years Following Treatment With Genotonorm — 3.07; 3.97; 2.84 cm/year — p=0.02922
Phase 3 N=5,449 Complementary Food Supplements for Reducing Childhood Undernutrition
Stunting · Wasting
Primary: Stunting in Children at 18 mo — 559; 542; 341; 300 Participants
N/A N=60 A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.
Height · Cognitive Function · Weight Gain
Primary: Change Mean Percentile Score in Double Trouble — 168.55; 129.46 percent change from baseline — p=0.488445